ARCHIVES

T-Cell Vaccines Cut Time To Protective Immunity

This article is from The Cancer Letter archive.

Vol. 28 No. 11 | November 25, 2005

Download PDF Visit The Full Archive

Related Articles

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

Firm’s Information System Embedded In iKnowMed For Treatment Outcomes.

June 29, 2001

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990

Chop Analysis Shows Program Had Major Impact In Communities

January 25, 1985

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014